NASDAQ:KDP - Keurig Dr Pepper Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $38.29
  • Forecasted Upside: 1.20 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$37.83
▼ -0.28 (-0.73%)

This chart shows the closing price for KDP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Keurig Dr Pepper Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for KDP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for KDP

Analyst Price Target is $38.29
▲ +1.20% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Keurig Dr Pepper in the last 3 months. The average price target is $38.29, with a high forecast of $42.00 and a low forecast of $33.00. The average price target represents a 1.20% upside from the last price of $37.83.

This chart shows the closing price for KDP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 8 polled investment analysts is to buy stock in Keurig Dr Pepper. This rating has held steady since October 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/27/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/26/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/24/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/23/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/22/2022

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/1/2021BarclaysBoost Price TargetOverweight$39.00 ➝ $41.00Medium
10/29/2021Royal Bank of CanadaBoost Price TargetOutperform$40.00 ➝ $41.00Low
9/20/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$35.00 ➝ $36.00High
6/29/2021Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$36.00 ➝ $42.00Low
5/3/2021Evercore ISIReiterated RatingHoldLow
4/30/2021Credit Suisse GroupBoost Price TargetNeutral$30.00 ➝ $33.00Medium
4/30/2021Morgan StanleyBoost Price TargetEqual Weight$34.00 ➝ $36.00Low
4/21/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$32.00 ➝ $33.00Low
3/19/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$33.00 ➝ $39.00Medium
3/12/2021Morgan StanleyReiterated RatingOverweight ➝ Equal WeightLow
3/11/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$34.00Low
2/26/2021Credit Suisse GroupBoost Price TargetNeutral$27.00 ➝ $30.00Medium
1/19/2021Sanford C. BernsteinInitiated CoverageOutperform$40.00Low
12/8/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$33.00High
12/7/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$33.00High
8/26/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$34.00Low
7/31/2020Morgan StanleyBoost Price TargetEqual Weight$30.00 ➝ $32.00High
7/27/2020Jefferies Financial GroupBoost Price TargetBuy$36.00 ➝ $39.00Medium
7/13/2020Morgan StanleyBoost Price TargetEqual Weight$29.00 ➝ $30.00Medium
7/9/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$27.00 ➝ $33.00Medium
6/11/2020Jefferies Financial GroupUpgradeHold ➝ Buy$36.00Low
6/1/2020Evercore ISIUpgradeIn-Line ➝ Outperform$35.00Low
4/30/2020Royal Bank of CanadaReiterated RatingBuy$31.00Low
4/29/2020BarclaysReiterated RatingBuyMedium
4/29/2020SunTrust BanksReiterated RatingBuyHigh
4/28/2020CitigroupBoost Price TargetNeutral$28.00 ➝ $31.00High
4/27/2020Morgan StanleyBoost Price TargetEqual Weight$25.00 ➝ $27.00High
4/22/2020Royal Bank of CanadaReiterated RatingBuy$31.00Low
4/1/2020The Goldman Sachs GroupReiterated RatingNeutral$25.00Medium
3/23/2020Royal Bank of CanadaReiterated RatingBuy$31.00Low
3/23/2020Morgan StanleyLower Price TargetEqual Weight$29.00 ➝ $25.00Medium
2/26/2020Royal Bank of CanadaReiterated RatingBuyMedium
2/23/2020Morgan StanleyUpgradeUnderweight ➝ Equal Weight$28.00 ➝ $29.00Medium
9/27/2019SunTrust BanksSet Price TargetBuy$35.00Low
9/27/2019GuggenheimReiterated RatingHoldLow
8/9/2019Royal Bank of CanadaSet Price TargetBuy$31.00N/A
8/9/2019Morgan StanleySet Price TargetSell$24.00N/A
8/9/2019Bank of AmericaBoost Price TargetBuy$30.00 ➝ $33.00N/A
7/17/2019Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$27.00Medium
6/17/2019BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$27.00 ➝ $34.00High
5/10/2019BMO Capital MarketsBoost Price TargetMarket Perform$25.00 ➝ $27.00Medium
4/11/2019Morgan StanleyDowngradeEqual Weight ➝ Underweight$27.30High
3/19/2019BarclaysReiterated RatingBuy$31.00Low
1/8/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$26.35High
12/21/2018Morgan StanleyInitiated CoverageEqual Weight ➝ Equal Weight$27.00Low
12/13/2018UBS GroupInitiated CoverageBuy ➝ Buy$32.00Low
12/7/2018SunTrust BanksInitiated CoverageBuy ➝ Buy$35.00Medium
12/4/2018MacquarieUpgradeNeutral ➝ Outperform$24.00 ➝ $30.00Low
11/16/2018JPMorgan Chase & Co.Initiated CoverageNeutral ➝ Neutral$30.00Low
11/13/2018CitigroupBoost Price TargetNeutral ➝ Hold$26.00 ➝ $30.00Medium
11/8/2018GabelliDowngradeBuy ➝ Hold$28.48Low
10/12/2018MacquarieSet Price TargetHold$20.00 ➝ $24.00Low
9/13/2018GuggenheimInitiated CoverageNeutral$22.00Low
8/20/2018Jefferies Financial GroupLower Price TargetHold ➝ Hold$25.00 ➝ $22.00Medium
8/10/2018CitigroupBoost Price TargetNeutral ➝ Neutral$15.46 ➝ $26.00N/A
7/25/2018Susquehanna BancsharesInitiated CoveragePositive$33.00Medium
7/18/2018The Goldman Sachs GroupInitiated CoverageNeutral$26.00Low
7/16/2018Bank of AmericaSet Price TargetBuy$30.00Low
7/11/2018Stifel NicolausInitiated CoverageHold$20.00High
(Data available from 1/22/2017 forward)

News Sentiment Rating

0.47 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/26/2021
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/26/2021
  • 7 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/25/2021
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/24/2021
  • 5 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
10/24/2021
  • 5 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/23/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/23/2021
  • 3 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/22/2022

Current Sentiment

  • 3 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Keurig Dr Pepper logo
Keurig Dr Pepper, Inc. engages in the production and marketing of non-alcoholic beverages. It operates through the following segments: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages. The Coffee Systems segment includes manufacture and distribution of finished goods relating to coffee, pods, and brewers. The Packaged Beverages segment offers finished beverages and other products, including own brands and third-party brands. The Beverage Concentrates sells branded concentrates and syrup to third-party bottlers. The Latin America Beverages segment refers to the sales in Mexico, the Caribbean, and other international markets from the production of concentrates, syrup, and finished beverages. The company was founded in 2018 and is headquartered in the Burlington, MA.
Read More

Today's Range

Now: $37.83
Low: $37.80
High: $38.71

50 Day Range

MA: $36.17
Low: $33.56
High: $39.28

52 Week Range

Now: $37.83
Low: $30.28
High: $39.35

Volume

6,085,955 shs

Average Volume

6,480,452 shs

Market Capitalization

$53.64 billion

P/E Ratio

31.26

Dividend Yield

1.97%

Beta

0.71

Frequently Asked Questions

What sell-side analysts currently cover shares of Keurig Dr Pepper?

The following Wall Street research analysts have issued research reports on Keurig Dr Pepper in the last year: Barclays PLC, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, JPMorgan Chase & Co., Morgan Stanley, Royal Bank of Canada, TheStreet, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for KDP.

What is the current price target for Keurig Dr Pepper?

7 Wall Street analysts have set twelve-month price targets for Keurig Dr Pepper in the last year. Their average twelve-month price target is $38.29, suggesting a possible upside of 1.2%. Wells Fargo & Company has the highest price target set, predicting KDP will reach $42.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $33.00 for Keurig Dr Pepper in the next year.
View the latest price targets for KDP.

What is the current consensus analyst rating for Keurig Dr Pepper?

Keurig Dr Pepper currently has 4 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe KDP will outperform the market and that investors should add to their positions of Keurig Dr Pepper.
View the latest ratings for KDP.

How do I contact Keurig Dr Pepper's investor relations team?

Keurig Dr Pepper's physical mailing address is 53 SOUTH AVENUE, BURLINGTON MA, 01803. The company's listed phone number is (877) 208-9991 and its investor relations email address is [email protected] The official website for Keurig Dr Pepper is www.keurigdrpepper.com.